MF
BNTX icon

Manchester Financial’s BioNTech BNTX Stock Holding History

Manchester Financial’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-48
Closed -$5K – 153
2021
Q1 		$5K Hold
48
– – ﹤0.01% 525
2020
Q4 		$4K Hold
48
– – ﹤0.01% 470
2020
Q3 		$3K Buy
+48
New +$3.44K ﹤0.01% 447

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Manchester Financial's BNTX Position: Q2 2021 in Review

Manchester Financial sold out of BioNTech (BNTX) in Q2 2021, closing a stake of 48 shares — an estimated $5K sold.

Manchester Financial first reported a position in BNTX in Q3 2020 and held it in 3 quarters. The position peaked at $5K in Q1 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2021.

  • Manchester Financial reported no remaining BioNTech position as of Q2 2021 after selling out during the quarter.
  • Manchester Financial sold 48 BioNTech shares in Q2 2021, an estimated $5K.
  • Manchester Financial first reported a position in BioNTech in Q3 2020 and held it in 3 quarters.
  • Manchester Financial's BioNTech position peaked at $5K in Q1 2021.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2021.

Based on Manchester Financial's 13F filing for Q2 2021, filed 21 Jul 2021.